{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:47:24Z","timestamp":1792547244404,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.tmrv.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T07:22:31Z","timestamp":1454138551000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["New Insights Into the Treatment of Glanzmann Thrombasthenia"],"prefix":"10.1016","volume":"30","author":[{"given":"Man-Chiu","family":"Poon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"d\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Zotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2016.01.001_bb0005","first-page":"1","article-title":"Hereditare hamorrhagische Thrombasthenia. Ein Beitrag zur Pathologie der Bluttplattchen","volume":"88","author":"Glanzmann","year":"1918","journal-title":"Jarbuch Kinderheilkd"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(66)90003-9","article-title":"Congenital bleeding disorders with long bleeding time and normal platelet count. 1. Glanzmann's thrombasthenia (report of fifteen patients)","volume":"41","author":"Caen","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0268-960X(02)00030-9","article-title":"Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment","volume":"16","author":"Bellucci","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-1-10","article-title":"Glanzmann thrombasthenia","volume":"1","author":"Nurden","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00001721-200206000-00011","article-title":"Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease","volume":"13","author":"Buyukasik","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0029-1145254","article-title":"Clinical utility of the PFA-100","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V11.11.965.965","article-title":"Thrombocytoasthenia and thrombocytopathia\u2014old names and new diseases","volume":"11","author":"Braunsteiner","year":"1956","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0040","first-page":"806","article-title":"Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases","volume":"34","author":"Reichert","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0045","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","article-title":"Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models","volume":"118","author":"Nurden","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V101.3.929","article-title":"Dynamics of GPIIb\/IIIa-mediated platelet-platelet interactions in platelet adhesion\/thrombus formation on collagen in vitro as revealed by videomicroscopy","volume":"101","author":"Patel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann's thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI109597","article-title":"Exposure of platelet fibrinogen receptors by ADP and epinephrine","volume":"64","author":"Bennett","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood.V61.6.1054.1054","article-title":"Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair","volume":"61","author":"di Minno","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V71.4.831.831","article-title":"The platelet membrane glycoprotein IIb-IIIa complex","volume":"71","author":"Phillips","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature02976","article-title":"Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics","volume":"432","author":"Xiao","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0080","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood-2008-06-077891","article-title":"The GPIIb\/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend","volume":"112","author":"Coller","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow","volume":"94","author":"Savage","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin\u2013dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ajh.20159","article-title":"Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran","volume":"77","author":"Toogeh","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1055\/s-0037-1613129","article-title":"Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients","volume":"87","author":"D'Andrea","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2009.10.016","article-title":"Glanzmann thrombasthenia: an update","volume":"411","author":"Franchini","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09537109876951","article-title":"The molecular genetics of Glanzmann's thrombasthenia","volume":"9","author":"French","year":"1998","journal-title":"Platelets"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0120","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2002-08-2452","article-title":"Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb\/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus","volume":"101","author":"Rosenberg","year":"2003","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2016.01.001_bb0125","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0135","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2008-02-139113","article-title":"The glycoprotein Ib-IX-V complex contributes to tissue factor\u2013independent thrombin generation by recombinant factor VIIa on the activated platelet surface","volume":"112","author":"Weeterings","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0140","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor\u2013independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0145","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2003-07-2287","article-title":"Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor\u2013independent fibrin generation","volume":"103","author":"Lisman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0150","series-title":"Platelets","article-title":"Factor VIIa","author":"Poon","year":"2012"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0155","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/S0021-9258(17)41800-X","article-title":"A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex","volume":"269","author":"Wilcox","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0160","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood.V98.8.2432","article-title":"A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype","volume":"98","author":"Ruiz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0165","series-title":"Bailli\u00e8res clinical haematology","first-page":"383","article-title":"Glanzmann's thrombasthenia","author":"Caen","year":"1972"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0170","series-title":"Bailli\u00e8res clinical haematology","first-page":"609","article-title":"Glanzmann's thrombasthenia","author":"Caen","year":"1979"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0175","first-page":"1378","article-title":"Glanzmann's thrombasthenia: modulation of clinical phenotype by alpha2C807T gene polymorphism","volume":"88","author":"D'Andrea","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0180","first-page":"1031","article-title":"The international prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes in non-surgical bleeding episodes in Glanzmann thrombasthenia patients","volume":"100","author":"di Minno","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0185","first-page":"1038","article-title":"The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention","volume":"100","author":"Poon","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0190","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1111\/hae.12017","article-title":"Pattern of bleeding and response to therapy in Glanzmann thrombasthenia","volume":"18","author":"Borhany","year":"2012","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2016.01.001_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2516.2011.02565.x","article-title":"How to deal with medical and social aspects of bleeding disorders\u2014preparing women and the family in developing countries","volume":"17","author":"Karimi","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0200","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","article-title":"Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia","volume":"94","author":"Poon","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0220","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1537-2995.2007.01108.x","article-title":"Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services","volume":"47","author":"O'Brien","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0225","article-title":"Bloody easy 3: blood transfusions, blood alternatives and transfusion reactions","author":"Callum","year":"2011","journal-title":"A guide to transfusion medicine third edition; Ontario Regional Blood Coordinating Network"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmrv.2005.05.002","article-title":"Bacterial detection of platelets: current problems and possible resolutions","volume":"19","author":"Blajchman","year":"2005","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tmrv.2009.11.001","article-title":"Blood still kills: six strategies to further reduce allogeneic blood transfusion\u2013related mortality","volume":"24","author":"Vamvakas","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/vox.12146","article-title":"Safety of platelet transfusion: past, present and future","volume":"107","author":"Katus","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0245","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1537-2995.2006.00790.x","article-title":"Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004","volume":"46","author":"Yomtovian","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0250","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1086\/529143","article-title":"Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets","volume":"46","author":"Jacobs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0255","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1537-2995.2011.03187.x","article-title":"Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk","volume":"51","author":"Jenkins","year":"2011","journal-title":"Transfusion"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2016.01.001_bb0265","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1111\/j.1537-2995.2009.02279.x","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1100\/tsw.2011.60","article-title":"Risk-reduction strategies for platelet transfusion in the United States","volume":"11","author":"Vamvakas","year":"2011","journal-title":"Sci World J"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.blre.2015.07.004","article-title":"Current concepts in the prevention of pathogen transmission via blood\/plasma-derived products for bleeding disorders","volume":"30","author":"Di Minno","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0280","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02965.x","article-title":"Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization","volume":"62","author":"Murphy","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0285","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V71.5.1402.1402","article-title":"Prevention of refractoriness and HLA-alloimmunization using filtered blood products","volume":"71","author":"Sniecinski","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0290","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group","volume":"337","author":"Slichter","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0300","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2516.2010.02230.x","article-title":"Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann thromboasthenia patients","volume":"16","author":"Santoro","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0305","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1111\/j.1365-2516.2011.02744.x","article-title":"Natural history of platelet antibody formation against alphaIIbbeta3 in a French cohort of Glanzmann thrombasthenia patients","volume":"18","author":"Fiore","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1423-0410.1988.tb03892.x","article-title":"Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions","volume":"54","author":"Brand","year":"1988","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002770050280","article-title":"Frequency and causes of refractoriness in multiply transfused patients","volume":"74","author":"Legler","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0320","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0037-1613041","article-title":"Detection of transfused platelets in a patient with Glanzmann thrombasthenia","volume":"87","author":"Nurden","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0325","first-page":"40","article-title":"Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies","volume":"61","author":"Ito","year":"1991","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0330","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03936.x","article-title":"Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies","volume":"119","author":"Martin","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0609.1981.tb00467.x","article-title":"Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia","volume":"27","author":"Sundqvist","year":"1981","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/HAB-1992-3206","article-title":"Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia)","volume":"3","author":"Jallu","year":"1992","journal-title":"Hum Antibodies Hybridomas"},{"issue":"ISSN 0340-6245","key":"10.1016\/j.tmrv.2016.01.001_bb0345","article-title":"Glanzmann thrombasthenia and pregnancy: clinical observations and management of four affected women","author":"Boval","year":"2001","journal-title":"Supplement to the journal Thrombosis and Haemostasis"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0350","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1111\/j.1365-2516.2011.02516.x","article-title":"A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia","volume":"17","author":"Siddiq","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0355","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1538-7836.2010.04152.x","article-title":"Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients","volume":"9","author":"Agers\u00f8","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0360","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2516.2004.00925.x","article-title":"Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A","volume":"10","author":"Villar","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0365","first-page":"640","article-title":"Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency","volume":"86","author":"Berrettini","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0370","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1182\/blood.V120.21.3341.3341","article-title":"The international prospective Glanzmann's Thrombasthenia Registry (GTR) special issues in children [abstract]","volume":"120","author":"Zotz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.thromres.2010.12.016","article-title":"In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver","volume":"127","author":"Seested","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0380","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1538-7836.2009.03696.x","article-title":"Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)","volume":"8","author":"Gopalakrishnan","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0385","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI118859","article-title":"Inhibition of platelet-mediated, tissue factor\u2013induced thrombin generation by the mouse\/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and \"clinical restenosis\"","volume":"98","author":"Reverter","year":"1996","journal-title":"J Clin Invest"},{"issue":"6 Suppl","key":"10.1016\/j.tmrv.2016.01.001_bb0390","first-page":"e58","article-title":"A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug","volume":"91","author":"Dargaud","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0395","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0400","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1538-7836.2005.01127.x","article-title":"The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia","volume":"3","author":"He","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0405","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1016\/j.ajpath.2011.02.026","article-title":"Redistribution and hemostatic action of recombinant activated factor VII associated with platelets","volume":"178","author":"Lopez-Vilchez","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1160\/TH03-05-0301","article-title":"Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles","volume":"91","author":"Proulle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0415","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/pbc.20365","article-title":"Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia","volume":"45","author":"Flood","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0420","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2141.1985.tb07358.x","article-title":"Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantation","volume":"59","author":"Bellucci","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1702139","article-title":"Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization","volume":"25","author":"Bellucci","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0430","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2007.06890.x","article-title":"Stem cell transplantation for children with Glanzmann thrombasthenia","volume":"140","author":"Connor","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0435","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pbc.21888","article-title":"Allogeneic stem cell transplantation for Glanzmann thrombasthenia","volume":"52","author":"Ishaqi","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0440","first-page":"147","article-title":"Bone marrow transplantation for Glanzmann's thrombasthenia","volume":"14","author":"Johnson","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0445","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1399-3046.2009.01251.x","article-title":"Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia","volume":"15","author":"Kitko","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0450","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.1997.3533167.x","article-title":"Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann's thrombasthenia","volume":"99","author":"McColl","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0455","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1273726","article-title":"Allogeneic hematopoietic stem cell transplantation in Glanzmann thrombasthenia complicated by platelet alloimmunization","volume":"223","author":"Wiegering","year":"2011","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1532\/IJH97.04044","article-title":"Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation","volume":"81","author":"Fujimoto","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0465","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood.V95.12.3645.012k51a_3645_3651","article-title":"Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia","volume":"95","author":"Wilcox","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0470","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2004-12-4619","article-title":"Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia","volume":"106","author":"Fang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0475","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.1016394108","article-title":"Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs","volume":"108","author":"Fang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2016.01.001_bb0480","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2013-10-530725","article-title":"High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia","volume":"123","author":"Sullivan","year":"2014","journal-title":"Blood"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779631600002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779631600002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T02:12:11Z","timestamp":1718331131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779631600002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S088779631600002X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.01.001","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights Into the Treatment of Glanzmann Thrombasthenia","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}